Cargando…
In Vivo and In Vitro Studies Establishing Haptoglobin as a Major Susceptibility Gene for Diabetic Vascular Disease
Hemoglobin (Hb) released during hemolysis is a potent oxidant. Extracorpuscular Hb may enter the vessel wall and mediate low-density lipoprotein oxidation, thereby promoting the development and progression of atherosclerosis. Haptoglobin (Hp) is an antioxidant protein as a result of its ability to b...
Autores principales: | Asleh, Rabea, Levy, Andrew P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993923/ https://www.ncbi.nlm.nih.gov/pubmed/17319095 |
Ejemplares similares
-
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
por: Schwartz, Avery, et al.
Publicado: (2009) -
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and Mice
por: Dahan, Inbal, et al.
Publicado: (2018) -
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008) -
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
por: Asleh, Rabea, et al.
Publicado: (2018) -
The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes
por: Somer, Shmuel, et al.
Publicado: (2020)